The Novel ATR Inhibitor BAY 1895344 Is Efficacious as Monotherapy and Combined with DNA Damage–Inducing or Repair–Compromising Therapies in Preclinical Cancer Models
Article in Molecular Cancer Therapeutics (January 2020)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Molecular Cancer Therapeutics (January 2020)
Article in Progress in Biophysics and Molecular Biology (June 2019)